Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 77 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pathological Complete Response after Monotherapy with Immune Checkpoint Inhibitors for Bifocal Colon Cancer in a Patient with Lynch Syndrome and Situs Inversus Totalis: a Case Report
Jun Feng, Wenbo Niu,Juan Zhang, Yuanyi Ding, Zheng Li, Jianfeng Zhang,Baokun Li, Chenhui Li, Feifei Wang,Guiying Wang, Bin Yu
Frontiers in immunology (2025): 1571607-1571607
Cited0Views0WOSBibtex
0
0
Folate-targeting and Reduction-Responsive Nano-Delivery System Based on Curcumin Polymer to Enhance the Anti-Cancer Activity
Wenjing Ren, Huiru Zhu, Dongshuai Shang, Xinyu Zhou,Hua Zhang,Juan Zhang, Guangpu Liu,Yunbo Wei,Kaiming Wang,Chengshi Jiang,Ping Sun
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2025)
Cited0Views0Bibtex
0
0
Design and Synthesis of 1,4-Diformyl-piperazine Ferrostatin-1 Derivatives As Novel Ferroptosis Inhibitors
Yi-Fan Zhang, Wei Guo, Hui Zheng,Nai-Yu Zhang, Hua-Long Ji,Ning Meng,Juan Zhang,Cheng-Shi Jiang
CHEMICAL BIOLOGY & DRUG DESIGNno. 5 (2024)
Cited0Views0WOSBibtex
0
0
Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydro-β-carboline Derivatives As Potential Antibacterial Agents
Yuan-Ze Song,Juan Zhang, Qing-Jiang Song, Wen-Hao Zhu, Chao Yuan,Kai-Ming Wang,Cheng-Shi Jiang
Bioorganic & Medicinal Chemistry Letters (2024): 129822-129822
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 77

#Citation: 1809

H-Index: 20

G-Index: 42

Sociability: 5

Diversity: 3

Activity: 26

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn